Skip to main content
OpenTrials
Completed

NCT Number: NCT04596709

Investigation of Blood Glucose and Insulin Response After Intake of Vitalose

The aim of this study is to assess the postprandial glucose and insulin response of Vitalose.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

BioTeSys GmbH

Esslingen am Neckar, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy adults
  • Age 18-50 years
  • BMI ≥18.5 and ≤30.0 kg/m²

Exclusion criteria

  • acute or chronic disease
  • food allergy or intolerance
  • intake of medications which affect glucose tolerance

Treatment and study plan

Vitalose

Dietary Supplement

dissolved in water

isomaltulose

Dietary Supplement

dissolved in water

Sucrose

Dietary Supplement

dissolved in water

Glucose

Dietary Supplement

dissolved in water

Primary outcomes

  1. 2h iAUC for pp glucose response

    Time frame: Baseline, 15, 30, 45, 60, 90, 120 minutes

  2. 2h iAUC for pp insulin response

    Time frame: Baseline, 15, 30, 45, 60, 90, 120 minutes

Sponsors and collaborators

Lead sponsor

Beneo-Institute

Industry

Collaborators

  • BioTeSys GmbH

Registry information

Official study title

Investigation of Blood Glucose and Insulin Response After Intake of Vitalose and Isomaltulose in Comparison to Sucrose and Glucose

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Oct 22, 2020
Registry last updated
Dec 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.